Basic Information
| RNALocate ID: | RLID:11001760 |
| RNA Symbol: | hsa-miR-138-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-138-5p |
| RNA ID: | miRBase:MIMAT0000430 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24797360 |
| Tissue/Cell Line: | Cerebrospinal fluid |
| Method: | RNA sequencing |
| Description: | Differentially expressed miRNAs detected in the cerebrospinal fluid (CSF). Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001777 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001778 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11001758 | Exosome | Brain tissue | 23382797 |
| RLID:11001759 | Exosome | Plasma | 23663360 |
| RLID-D:11000081 | Exosome | Blood|Endothelial cells | |
| RLID-D:11000358 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-138-5p | Splenic marginal zone lymphoma | MNDR-E-MI-12878 |
| MNDR | hsa-miR-138-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-12879 |
| MNDR | hsa-miR-138-5p | Tongue squamous cell carcinoma | MNDR-E-MI-12880 |
| MNDR | hsa-miR-138-5p | Oral squamous cell carcinoma | MNDR-E-MI-12881 |
| MNDR | hsa-miR-138-5p | Large cell neuroendocrine cancer | MNDR-E-MI-12882 |
| MNDR | hsa-miR-138-5p | Medulloblastoma | MNDR-E-MI-12883 |
| MNDR | hsa-miR-138-5p | Ovarian clear cell carcinoma | MNDR-E-MI-12884 |
| MNDR | hsa-miR-138-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-12885 |
| MNDR | hsa-miR-138-5p | Lymphoma | MNDR-E-MI-12886 |
| MNDR | hsa-miR-138-5p | Lymphoma non-hodgkin | MNDR-E-MI-12887 |
| MNDR | hsa-miR-138-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-12888 |
| MNDR | hsa-miR-138-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-12889 |
| MNDR | hsa-miR-138-5p | Her2-receptor positive breast cancer | MNDR-E-MI-12890 |
| MNDR | hsa-miR-138-5p | Anencephaly | MNDR-E-MI-12891 |
| MNDR | hsa-miR-138-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-12892 |
| MNDR | hsa-miR-138-5p | Anaplastic thyroid carcinoma | MNDR-E-MI-12893 |
| MNDR | hsa-miR-138-5p | Gastric cancer | MNDR-E-MI-12894 |
| MNDR | hsa-miR-138-5p | Gastric lymphoma | MNDR-E-MI-12895 |
| MNDR | hsa-miR-138-5p | Alzheimer disease | MNDR-E-MI-12896 |
| MNDR | hsa-miR-138-5p | Attention deficit hyperactivity disorder | MNDR-E-MI-12897 |
| MNDR | hsa-miR-138-5p | Bladder cancer | MNDR-E-MI-12898 |
| MNDR | hsa-miR-138-5p | Dysautonomia familial | MNDR-E-MI-12899 |
| MNDR | hsa-miR-138-5p | Head and neck cancer | MNDR-E-MI-12900 |
| MNDR | hsa-miR-138-5p | Huntington disease | MNDR-E-MI-12901 |
| MNDR | hsa-miR-138-5p | Lung cancer | MNDR-E-MI-12902 |
| MNDR | hsa-miR-138-5p | Fragile x syndrome | MNDR-E-MI-12903 |
| MNDR | hsa-miR-138-5p | Parkinson disease | MNDR-E-MI-12904 |
| MNDR | hsa-miR-138-5p | Breast cancer | MNDR-E-MI-12905 |
| MNDR | hsa-miR-138-5p | Neuroendocrine neoplasia | MNDR-E-MI-12906 |
| MNDR | hsa-miR-138-5p | Squamous cell carcinoma | MNDR-E-MI-12907 |
| MNDR | hsa-miR-138-5p | Thyroid cancer | MNDR-E-MI-12908 |
| MNDR | hsa-miR-138-5p | Pancreatic cancer | MNDR-E-MI-12909 |
| MNDR | hsa-miR-138-5p | Melanoma | MNDR-E-MI-12910 |
| MNDR | hsa-miR-138-5p | Nephroblastoma | MNDR-E-MI-12911 |
| MNDR | hsa-miR-138-5p | Colon cancer | MNDR-E-MI-12912 |
| MNDR | hsa-miR-138-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-12913 |
| MNDR | hsa-miR-138-5p | Glioblastoma | MNDR-E-MI-12914 |
| MNDR | hsa-miR-138-5p | Astrocytoma | MNDR-E-MI-12915 |
| MNDR | hsa-miR-138-5p | Glioma | MNDR-E-MI-12916 |
| MNDR | hsa-miR-138-5p | Gallbladder cancer | MNDR-E-MI-12917 |
| MNDR | hsa-miR-138-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-12918 |
| MNDR | hsa-miR-138-5p | Epilepsy temporal lobe | MNDR-E-MI-12919 |
| MNDR | hsa-miR-138-5p | Osteosarcoma | MNDR-E-MI-12920 |
| MNDR | hsa-miR-138-5p | Gastric adenocarcinoma | MNDR-E-MI-12921 |
| MNDR | hsa-miR-138-5p | Lung squamous cell carcinoma | MNDR-E-MI-12922 |
| MNDR | hsa-miR-138-5p | Non-small cell lung cancer | MNDR-E-MI-12923 |
| MNDR | hsa-miR-138-5p | Lung adenocarcinoma | MNDR-E-MI-12924 |
| MNDR | hsa-miR-138-5p | Thyroid carcinoma | MNDR-E-MI-12925 |
| MNDR | hsa-miR-138-5p | Bladder urothelial carcinoma | MNDR-E-MI-12926 |
| MNDR | hsa-miR-138-5p | Pancreatic adenocarcinoma | MNDR-E-MI-12927 |
| MNDR | hsa-miR-138-5p | Cervical cancer | MNDR-E-MI-12928 |
| MNDR | hsa-miR-138-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-12929 |
| MNDR | hsa-miR-138-5p | Renal carcinoma | MNDR-E-MI-12930 |
| MNDR | hsa-miR-138-5p | Clear cell renal cell carcinoma | MNDR-E-MI-12931 |
| MNDR | hsa-miR-138-5p | Cholangiocarcinoma | MNDR-E-MI-12932 |
| MNDR | hsa-miR-138-5p | Gallbladder carcinoma | MNDR-E-MI-12933 |
| MNDR | hsa-miR-138-5p | Esophageal cancer | MNDR-E-MI-12934 |
| MNDR | hsa-miR-138-5p | HIV | MNDR-E-MI-12935 |
| MNDR | hsa-miR-138-5p | Small cell lung cancer | MNDR-E-MI-12936 |
| MNDR | hsa-miR-138-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-12937 |
| MNDR | hsa-miR-138-5p | Heart failure | MNDR-E-MI-12938 |
| MNDR | hsa-miR-138-5p | Pulmonary arterial hypertension | MNDR-E-MI-12939 |
| MNDR | hsa-miR-138-5p | Hepatocellular carcinoma | MNDR-E-MI-12940 |
| MNDR | hsa-miR-138-5p | B-cell lymphoma | MNDR-E-MI-12941 |
| MNDR | hsa-miR-138-5p | T-cell leukemia | MNDR-E-MI-12942 |
| MNDR | hsa-miR-138-5p | Malignant pleural mesothelioma | MNDR-E-MI-12943 |
| MNDR | hsa-miR-138-5p | Retinoblastoma | MNDR-E-MI-12944 |
| MNDR | hsa-miR-138-5p | Thyroid hurthle cell carcinoma | MNDR-E-MI-12945 |
| MNDR | hsa-miR-138-5p | Osteoarthritis | MNDR-E-MI-12946 |
| MNDR | hsa-miR-138-5p | Burkitt lymphoma | MNDR-E-MI-12947 |
| MNDR | hsa-miR-138-5p | Psoriasis | MNDR-E-MI-12948 |
| MNDR | hsa-miR-138-5p | Skin cutaneous melanoma | MNDR-E-MI-12949 |
| MNDR | hsa-miR-138-5p | Skin melanoma | MNDR-E-MI-12950 |
| MNDR | hsa-miR-138-5p | Colorectal cancer | MNDR-E-MI-12951 |
| MNDR | hsa-miR-138-5p | Nasopharyngeal carcinoma | MNDR-E-MI-12952 |
| MNDR | hsa-miR-138-5p | Type 2 diabetes mellitus | MNDR-E-MI-12953 |
| MNDR | hsa-miR-138-5p | Acute lymphocytic leukemia | MNDR-E-MI-12954 |
| MNDR | hsa-miR-138-5p | Ependymoma | MNDR-E-MI-12955 |
| MNDR | hsa-miR-138-5p | Nasopharyngeal cancer | MNDR-E-MI-12956 |
| MNDR | hsa-miR-138-5p | Prostatic neoplasms | MNDR-E-MI-12957 |
| MNDR | hsa-miR-138-5p | Sleep deprivation | MNDR-E-MI-12958 |
| MNDR | hsa-miR-138-5p | Myocardial ischemia | MNDR-E-MI-12959 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ADGRA2 | Homo sapiens | RR00045532 |
TOP